Marshall & Sterling Wealth Advisors Inc. Bristol Myers Squibb CO Transaction History
Marshall & Sterling Wealth Advisors Inc.
- $147 Billion
- Q1 2025
A detailed history of Marshall & Sterling Wealth Advisors Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Marshall & Sterling Wealth Advisors Inc. holds 423 shares of BMY stock, worth $19,978. This represents 0.02% of its overall portfolio holdings.
Number of Shares
423
Previous 267
58.43%
Holding current value
$19,978
Previous $15.1 Million
70.83%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,810Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.04 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.49 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.1 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.48 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.14 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $100B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...